Filing Details
- Accession Number:
- 0001209191-23-026991
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-05-03 16:44:20
- Reporting Period:
- 2023-05-01
- Accepted Time:
- 2023-05-03 16:44:20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1643921 | N. Sangeeta Bhatia | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-05-01 | 1,168 | $0.00 | 5,208 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2023-05-02 | 62 | $345.93 | 5,146 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-05-02 | 172 | $346.69 | 4,974 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-05-02 | 120 | $348.16 | 4,854 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-05-02 | 163 | $349.82 | 4,691 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-05-02 | 63 | $351.20 | 4,628 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date.
- Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1, which was entered into on 05/17/2022.
- Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $345.93 (range $345.20 to $346.12).
- Open market sales reported on this line occurred at a weighted average price of $346.69 (range $346.31 to $347.03).
- Open market sales reported on this line occurred at a weighted average price of $348.16 (range $347.91 to $348.64).
- Open market sales reported on this line occurred at a weighted average price of $349.82 (range $349.17 to $350.08).
- Open market sales reported on this line occurred at a weighted average price of $351.20 (range $350.92 to $351.48).
Billionaire Hedge Funds
